The ALS Association’s new initiative, TREAT ALS (Translational Research Advancing Therapy for ALS) ultimate goal is to capitalize on scientific and technological progress to accelerate drug discovery and realize effective new therapy,” said Lucie Bruijn, Ph.D., the ALS Association Science Director and Vice President. “We understand far more about the biological basis of the disease and this knowledge has enabled design of laboratory models of ALS that have yielded innovative ideas and novel treatment strategies."
Already partnering with many organizations around the world, including The National Institutes of Health (NIH), the largest single investor in research globally, The ALS Association brings together an expert team of scientific and business advisors to steer this initiative. “As part of this initiative we will support the development of novel compounds for large scale, U.S. Food and Drug Administration-approved clinical trials and engage in small pilot trials of existing FDA-approved drugs,” said Bruijn.
Noted biologist Tom Maniatis, Ph.D., Professor of Molecular and Cellular Biology at Harvard University and head of the ALS Association-initiated program says, “TREAT ALS is an exciting initiative that will translate advances in research in academia and industry into drug development and clinical trials. I look forward to working with an outstanding group of scientists and neurologists on the TREAT ALS steering committee to intensify the search for an ALS cure.”
ALS is a brutal disease that robs patients of all muscle and body control. Eventually every patient diagnosed with ALS loses the ability to walk, eat and even breathe. Despite advances in treatment and therapies, like TREAT ALS, there is no cure. ALS is fatal.
Every year ALSA Wisconsin allocates funds toward national research initiatives like TREAT ALS. Donate to ALSA.org this Giving Tuesday because initiatives like TREAT ALS benefit all ALS patients — both in our community and across the country.
Every year ALSA Wisconsin allocates funds toward national research initiatives like TREAT ALS. Donate this Giving Tuesday because initiatives like TREAT ALS benefit all ALS patients — both in our community and across the country.